Overview of a not-so-rare ENT disease we see in the ED.
Read More
Core Content edited by
Core
The Red Eye
A systematic approach to the red eye: an often intimidating chief complaint.
Read More
Post
The Silence After
“There are some things you learn best in calm, and some in storm.”
– Willa Cather
Over the past several years, I’ve thought a lot about what to say during the immediate moments after a failed cardiac arrest or traumatic resuscitation. When the rush of adrenaline comes to a screeching halt and all that is left is a deafening silence,
Read More
Core
Posterior Circulation Stroke
Diagnosis and management of this often missed, potentially devastating neurological disease.
Read More
Journal Review
Early Subthreshold Aerobic Exercise for Sport-Related Concussion: A Randomized Clinical Trial.
Recommendations that “rest is best” for concussions are based on animal research and consensus opinion. Recent evidence suggests that strict limitation of activity may not be beneficial. A small clinical trial (n=88) of pediatric patients with acute concussion randomized patients to “strict rest” for 5 days and “usual care” defined as 1-2 days of rest and then a gradual return to activities.
Read More
Core
Post-Infectious Glomerulonephritis
A look at this post-infectious process that can range from asymptomatic hematuria to florid renal failure and acute nephrotic syndrome.
Read More
Post
PEMCARS (Pediatric Emergency Medicine Critical Article Review) V3.0, 2019
The new version of the PEM CARS iBook (V3.0, 2019) has been released! 200 comprehensive, critical article reviews on PEM literature available for free.
Download the PDF
Access the Apple Book
Congratulations and many thanks to the NYU/Bellevue Pediatric Emergency Medicine fellows and faculty that have put in a considerable amount of effort to make this happen.
Read More
Journal Review
Effects of Tranexamic Acid on Death, Disability, Vascular Occlusive Events and Other Morbidities in Patients with Acute Traumatic Brain Injury (CRASH-3): A Randomised, Placebo-Controlled Trial
Head trauma is a leading cause of trauma related morbidity and mortality worldwide. Tranexamic acid (TXA) inhibits fibrinolysis and can decrease ongoing hemorrhage. In the CRASH-2 Trial, TXA given within 3 hours of injury was shown to decrease mortality from major extracranial injury (CRASH 2 Investigators, Lancet. 2010. PMID: 20554319). A subgroup analysis of the CRASH 2 study that included 270 patients who met criteria for trauma with concern for hemorrhage and a GCS <
Read More